Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion
Pancreatic cancer has a high mortality rate due to metastasis. Whereas KRAS is mutated in most pancreatic cancer patients, controlling KRAS or its downstream effectors has not been succeeded clinically. ARL4C is a small G protein whose expression is induced by the Wnt and EGF–RAS pathways. In the pr...
Guardado en:
Autores principales: | Akikazu Harada, Shinji Matsumoto, Yoshiaki Yasumizu, Kensaku Shojima, Toshiyuki Akama, Hidetoshi Eguchi, Akira Kikuchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5fbe9fa95757439f8c5ea656d83a9bfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ARL3 and ARL13B GTPases participate in distinct steps of INPP5E targeting to the ciliary membrane
por: Sayaka Fujisawa, et al.
Publicado: (2021) -
Necrotizing enterocolitis totalis complicates an infantile presentation of ARL6IP1-related spastic paraplegia 61
por: E.K. Ninmer, et al.
Publicado: (2021) -
LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression
por: Liu Weiwei, et al.
Publicado: (2021) -
Disruption of Glycolysis by Nutritional Immunity Activates a Two-Component System That Coordinates a Metabolic and Antihost Response by <named-content content-type="genus-species">Staphylococcus aureus</named-content>
por: Paola K. Párraga Solórzano, et al.
Publicado: (2019) -
Knockdown of ZFR suppresses cell proliferation and invasion of human pancreatic cancer
por: Zhao,Xiaolan, et al.
Publicado: (2016)